Skip to content

Physiological responses to discomfort induced by the use of technological rehabilitation devices in children

Physiological responses to discomfort induced by the use of technological rehabilitation devices in children - Discomfort induced by technological rehabilitation in children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49063
Enrollment
12
Registered
2020-11-09
Start date
2021-05-22
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

None listed

Sponsors

Sint Maartenskliniek
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Typically Developing (TD) children: - Aged 12 to 14 years old Children with Cerebral Palsy (CP) (only if the results of TD children are promising): - Aged 12 to 14 years old - Diagnosis of CP - GMFCS level I or II

Exclusion criteria

Exclusion criteria: TD children: - Motor problems indicated by parents - Visual problems not corrected by glasses - Conditions that influence walking ability (such as a sprained ankle or growing pains) - Epilepsy - Experience with walking on a treadmill Children with CP: - Visual or cardiovascular problems - Temporary complaints influencing walking (such as a sprained ankle or growing pains) - Epilepsy - Experience with walking on a treadmill

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is level of discomfort, measured with the CAPTIV system (see paragraph 8.3 of the protocol). Respiration rate, 3D movement, electrodermal activity, skin temperature, and heart rate will be determined, which will serve as input for a discomfort recognition algorithm to measure the level of discomfort.

Secondary

MeasureTime frame
The Visual Analog Scale will be used to indicate the amount of discomfort during the experiments.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)